EUVIMED · CrossrefZeitschrift
Targetome
ISSN 3070-3808 · Maximum Academic Press
Neueste Artikel
Proteome-wide dose-response measurements for the characterization of drug mechanism of action
Artificial intelligence algorithms drive the deciphering of traditional Chinese medicine by analyzing the chemicalome, targetome, and bioactivome
Transfer learning algorithm assisted in the discovery of novel gp130 inhibitors and their application in colorectal cancer treatment
OPTAR: a computational tool for target discovery based on disease correlation inference from literature of interacting proteins
Degradation-based protein profiling in target identification and early-stage drug discovery of bioactive natural products
Biomedical knowledge graphs driving new target identification and novel drug discovery
Immunosenescence-driven bone marrow immune niche destabilization in osteoporosis: microenvironmental targets and natural product-mediated reprogramming
Omics-driven target discovery and multi-target therapeutic strategies for ischemic cardio-cerebrovascular diseases
Molecular glues: from mechanistic insights to rational design in a new era of targeted therapy
Dual targeting of MAPK8 and JAK2 as a host-directed anti-inflammatory strategy for severe Klebsiella pneumoniae infection
Expert consensus on the clinical application of donafenib tosilate for hepatocellular carcinoma (2026 edition)
Reigniting tumor-reactive immunity with oncolytic herpes simplex virus: a strategy to address PD-1 resistance in melanoma
Context-dependent cGAS–STING signaling drives disease pathogenesis and therapeutic innovation
Recent advances and structural evolution of small-molecule PD-L1 inhibitors (2021−2025): from classic biphenyl iterations to novel heterocyclic scaffolds
Genetic and pharmacological targeting of SNAI1 attenuates liver fibrosis in mice
Carbonic anhydrase IX-targeted imaging and therapy in cancer: recent progress and challenges
Ganjie decoction alleviates RSV-induced pneumonia by suppressing ferroptosis with NRF2/SLC7A11/GPX4 pathway activation
GSDME-mediated pyroptosis in cardiovascular diseases
Gut microbial enzymes as mediators and targets of traditional Chinese medicine and its constituents: from biotransformation to therapeutic translation
Targeting hypoxia-inducible factors to overcome immunotherapy resistance
Navigating drug discovery with Targetome
Targetome-guided combination drug discovery as next-generation therapeutics
Harnessing RNA molecules for therapy: advances in design, delivery, and clinical development
Combination of silybin and carvedilol synergistically alleviates liver fibrosis by inhibiting Wnt/β-catenin signaling
Glial Wnt dialogue controls synapses
From rare to prevalent: dawn of the RNA therapeutics era
Targeting the peroxisomal FASN-ACOX2 axis to modulate energy homeostasis: therapeutic potential and challenges
Saving the "brain rainforest" in Alzheimer's disease: from single-node protection to ecosystem restoration
Novel strategies for lipid-independent atherosclerosis intervention
iNKT cells: an emerging promise for immunotherapy
EUVIMED